Plasma inhibitors of the Hageman factor dependent pathways

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Hageman factor-dependent pathways are critical for hemostasis.
• Several control proteins modulate these pathways, influencing enzyme activation and biological activity.

Purpose of the Study:

• To elucidate the roles of specific control proteins in Hageman factor-dependent pathways.
• To highlight the clinical significance of deficiencies in these regulatory proteins.

Main Methods:

• Review of literature on Hageman factor pathways and associated control proteins.
• Analysis of the functional mechanisms of C1 INH, alpha-2 macroglobulin, and antithrombin.

Main Results:

• C1 inhibitor (C1 INH) regulates the initiation of Hageman factor pathways; its deficiency causes disease.
• Alpha-2 macroglobulin shows potent activity in the fibrinolytic system.
• Antithrombin regulates coagulation factors (XI, IX, X, thrombin); its deficiency increases thrombosis risk.

Conclusions:

• Control proteins are essential regulators of Hageman factor-dependent systems.
• Deficiencies in C1 INH and antithrombin have direct and severe clinical consequences in humans, including disease and thrombosis.